Get the latest news, insights, and market updates on CI (The Cigna Group). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
BrainsWay Reports Cigna’s Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to Care
BURLINGTON, Mass. and JERUSALEM, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today commented on the recent news issued by Evernorth® Behavioral Health, Inc., a division of the Cigna Group, which serves over 18 million covered lives across 12 states, that it will no longer require prior authorization for transcranial magnetic stimulation (TMS) for contracted providers Feb 18, 2026 - $CI
Cigna Disaster Drug Donations Tie Evernorth Capabilities To Undervalued Story
Cigna Group's Evernorth unit has partnered with humanitarian group Direct Relief on a new prescription medication donation pathway. The program is designed to source and distribute surplus prescription drugs to support disaster and emergency response efforts. The collaboration creates a framework for humanitarian organizations to obtain prescriptions directly from participating pharmacies. Cigna Group (NYSE:CI), through its Evernorth health services segment, is tying its healthcare... Feb 13, 2026 - $CI
Evernorth Health Services Teams Up with Direct Relief To Deliver Critical Medications to Communities Impacted by Disasters
Evernorth, the health services division of The Cigna Group (NYSE: CI), has partnered with Direct Relief to donate more than 41,000 lifesaving prescription medications for rapid deployment during natural disasters and other emergencies. Through this collaboration, Evernorth's Express Scripts Pharmacy has created a first–of–its–kind donation pathway that enables humanitarian organizations to source prescription medications directly from pharmacies, helping bridge the gap between unused supply and Feb 12, 2026 - $CI
5 Revealing Analyst Questions From Cigna’s Q4 Earnings Call
Cigna’s fourth quarter results were well received by the market, reflecting the company’s ability to navigate industry disruptions and deliver on key growth priorities. Management credited the quarter’s performance to robust expansion in its EverNorth specialty and care services, successful adoption of biosimilars, and operational discipline across its health benefits business. CEO David Cordani highlighted the company’s strategic investments, including the new pharmacy benefits model and expand Feb 12, 2026 - $CI
1 Safe-and-Steady Stock with Exciting Potential and 2 We Brush Off
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. Feb 11, 2026 - $CI
CVS holds 2026 guidance steady as turnaround plan bears fruit
The healthcare giant outperformed to close out 2025, and expects its finances to improve further this year. Still, proposed Medicare Advantage rates could be an issue moving forward. Feb 10, 2026 - $CI
Cigna to lay off 2,000 workers worldwide
Cigna’s layoffs follow other recent downsizing announcements from health insurers looking to cut costs during an era of heightened medical spending. Feb 10, 2026 - $CI
How Investors Are Reacting To Cigna Group (CI) Earnings Beat, Massive Buybacks And Dividend Hike
The Cigna Group recently reported full-year 2025 results showing higher sales, revenue, and net income, alongside completing a multi-year share repurchase program of about US$35.46 billion and announcing a higher quarterly dividend of US$1.56 per share. Together, the stronger earnings, extensive buybacks, and dividend increase highlight Cigna’s emphasis on returning capital to shareholders while peers contend with policy uncertainty. We’ll now examine how Cigna’s increased dividend informs... Feb 10, 2026 - $CI
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple